What Is a Bicuspid Aortic Valve and Why Does It Matter?
A normal aortic valve has three leaflets — thin flaps of tissue that open and close with every heartbeat to let blood flow from the heart into the aorta. A bicuspid aortic valve (BAV) has only two functional leaflets instead of three. It is the most common congenital heart defect, affecting roughly 1 to 2 percent of the general population, and it is about three times more common in men than women.
Many people with a bicuspid aortic valve live for decades without symptoms. Some never need surgery at all. But a bicuspid valve is not simply a normal valve with one fewer leaflet — it changes the mechanical stress on the valve tissue and, critically, it is associated with abnormalities of the aortic wall itself. Over time, these factors can lead to aortic stenosis (narrowing), aortic regurgitation (leaking), aortic dilation, or even aortic dissection.
The key challenge for patients and their physicians is determining when a bicuspid aortic valve has moved from something you monitor to something you treat — and what the right treatment is when that time comes. That decision is not always straightforward, and it is exactly the kind of decision where a cardiac surgery second opinion can provide critical clarity.
BAV Treatment Options: From Surveillance to Surgery
The spectrum of BAV treatment options is broad, ranging from watchful monitoring to complex surgical reconstruction. Where you fall on that spectrum depends on several factors: your valve function, the size of your aorta, your symptoms, your age, and the trajectory of disease progression over time.
Surveillance and Medical Management
If your bicuspid aortic valve is functioning well — meaning it is neither significantly stenotic nor significantly leaky — the primary approach is regular surveillance. According to the 2020 ACC/AHA Guidelines for the Management of Valvular Heart Disease, patients with a known BAV should undergo:
- A baseline echocardiogram to assess valve function and aortic dimensions
- A CT angiogram or MRI of the thoracic aorta to evaluate the entire ascending aorta and arch (echocardiography alone may not capture the full picture)
- Repeat imaging at intervals determined by findings — typically every 1 to 3 years for stable disease, more frequently if the aorta is dilated or the valve is worsening
Medical management may include blood pressure control — particularly with beta-blockers or ARBs — to reduce wall stress on a dilated aorta. However, no medication can stop or reverse the progression of valve calcification or aortic dilation. Medications buy time; they do not eliminate the underlying problem.
Aortic Valve Repair
In select patients — particularly younger individuals with significant aortic regurgitation from a bicuspid valve — valve repair may be an option. Repair avoids the need for a prosthetic valve entirely, which means no lifelong anticoagulation (blood thinners) and potentially better long-term durability in the right hands.
Bicuspid valve repair is technically demanding. Outcomes are highly dependent on surgical expertise, and not every BAV is anatomically suitable for repair. Studies from specialized centers report 10-year freedom from reoperation in the range of 80 to 90 percent after bicuspid valve repair, but these results come from high-volume surgeons at experienced institutions. If valve repair has been discussed as an option for you, it is worth confirming that your surgeon has a meaningful track record with this specific operation.
Aortic Valve Replacement
When the valve is severely stenotic, heavily calcified, or not amenable to repair, aortic valve replacement is the standard treatment. Patients face a choice between two types of prosthetic valves:
- Mechanical valves — extremely durable (often lasting a lifetime) but requiring lifelong warfarin anticoagulation with regular blood monitoring. Typically considered for younger patients, often under age 50 to 55.
- Bioprosthetic (tissue) valves — made from animal tissue, these do not require long-term anticoagulation but have limited durability. In younger patients, a tissue valve may wear out in 10 to 20 years, potentially requiring reoperation or a future transcatheter valve-in-valve procedure.
The valve choice is deeply personal and involves trade-offs between lifestyle, bleeding risk, reoperation risk, and life expectancy. I discuss this decision at length with every patient because the "right" valve depends on the individual, not a formula.
A note on TAVR (transcatheter aortic valve replacement): While TAVR has transformed treatment for older patients with aortic stenosis, it is not currently the standard of care for most bicuspid valve patients. BAV anatomy — with its asymmetric leaflets, variable calcification patterns, and associated aortopathy — makes transcatheter valve deployment more complex and less predictable. The ACC/AHA guidelines continue to recommend surgical aortic valve replacement (SAVR) for younger, lower-risk patients with bicuspid valves. TAVR may have a role in select cases, but this is a decision that deserves careful scrutiny. You can learn more about the nuances of aortic stenosis treatment on our conditions page.
Aortic Root and Ascending Aorta Surgery
This is the part of BAV management that is most frequently under-discussed. Approximately 40 to 50 percent of patients with a bicuspid aortic valve have some degree of aortic dilation — an enlargement of the ascending aorta that occurs because the same genetic and structural abnormalities that produced the bicuspid valve also weaken the aortic wall.
When the ascending aorta reaches a certain size, the risk of aortic dissection or rupture increases significantly, and prophylactic surgical replacement of the aorta becomes necessary. Current guidelines generally recommend surgery when:
- The ascending aorta reaches 5.5 cm in diameter in patients without additional risk factors
- The ascending aorta reaches 5.0 cm in patients with risk factors such as a family history of dissection, rapid growth rate (greater than 0.5 cm per year), aortic coarctation, or planned pregnancy
- The aorta is 4.5 cm or larger and the patient already requires valve surgery for another indication — in this case, replacing the aorta at the same time is prudent
Aortic surgery in BAV patients may involve replacing just the ascending aorta (a supracoronary graft), performing a full aortic root replacement (a Bentall procedure), or — in carefully selected cases — a valve-sparing root replacement (a David or Yacoub procedure) that preserves the patient's own valve while replacing the diseased aorta around it.
Bicuspid Valve Surgery Timing: How Surgeons Decide When to Operate
One of the most important and nuanced questions in BAV management is bicuspid valve surgery timing. Operate too early and you expose a patient to surgical risk they did not yet need. Operate too late and you risk irreversible damage to the heart or a catastrophic aortic event.
Here is how I think about timing:
For aortic stenosis: Surgery is indicated when the valve is severely stenotic (valve area less than 1.0 cm², mean gradient greater than 40 mmHg) and the patient has symptoms — chest pain, shortness of breath, syncope, or reduced exercise tolerance. Increasingly, guidelines also support earlier intervention in asymptomatic severe stenosis when there is evidence of declining heart function (ejection fraction dropping below 55%) or an abnormal exercise test.
For aortic regurgitation: Surgery is indicated for severe regurgitation with symptoms, or in asymptomatic patients whose left ventricle is dilating or whose ejection fraction is falling. Waiting until the heart muscle is severely weakened means you may never fully recover normal cardiac function, even after a successful operation.
For aortic dilation: The size thresholds I described above guide the decision. But I want to emphasize something that raw numbers do not capture — the rate of growth matters as much as the absolute size. An aorta that grows from 4.2 to 4.8 cm in a single year is more alarming than one that has been stable at 4.8 cm for five years. This is why serial imaging with consistent measurement techniques is essential.
If your doctor has recommended surgery and you are unsure about the timing, or if you have been told to "keep watching" but the numbers seem to be changing, consider using our free cardiac surgery risk calculator to understand your estimated surgical risk. It is one piece of the puzzle, but it helps frame the conversation.
What Patients With a Bicuspid Aortic Valve Should Know About Long-Term Outcomes
Living with a bicuspid aortic valve is a lifelong reality, not a one-time event. Even after successful surgery, ongoing surveillance is necessary because:
- Prosthetic valves — whether mechanical or tissue — require monitoring for function and potential complications
- If only the valve was addressed, the aorta still needs to be followed for potential late dilation
- BAV has a genetic component — first-degree relatives (parents, siblings, children) have approximately a 9 to 10 percent chance of also having a bicuspid valve and should be screened with echocardiography
The good news is that outcomes after bicuspid aortic valve surgery are generally excellent. Operative mortality for elective aortic valve replacement in otherwise healthy patients is typically in the range of 1 to 3 percent, and combined valve-plus-aorta operations at experienced centers carry only modestly higher risk. The key is having the right operation, at the right time, by the right surgeon.
Why a Second Opinion Matters for Bicuspid Aortic Valve Decisions
BAV management sits at the intersection of several complex decisions: valve repair versus replacement, mechanical versus tissue prosthesis, when to intervene on the aorta, and whether concomitant procedures are needed. I have reviewed cases where patients were told they needed urgent surgery when continued surveillance was appropriate — and cases where patients were told to wait when the data clearly supported earlier intervention.
These are not decisions that should be made in haste or based on a single opinion. A second set of eyes — particularly from a surgeon who is not performing the operation — can provide the objectivity and clarity that patients deserve.
You can see exactly how our review process works — it is straightforward, thorough, and designed to give you actionable information without requiring you to travel or wait weeks for an appointment.
Making an Informed Decision About Your Bicuspid Aortic Valve
If you have been diagnosed with a bicuspid aortic valve and are facing questions about surveillance intervals, the need for surgery, the type of procedure recommended, or the right timing for intervention, you are not alone — and you do not need to make this decision in the dark.
Gather your imaging, your operative reports if you have prior surgeries, and any relevant test results. Ask your current team specific questions: What is the current valve area or degree of regurgitation? What is my aortic diameter and how has it changed? What is my estimated surgical risk? These data points form the foundation of any sound recommendation.
If you are facing a decision about bicuspid aortic valve treatment — whether it is your first discussion about surgery or a recommendation you are not sure about — a WhiteGloveMD second opinion can help you understand your options, validate or challenge the current plan, and move forward with confidence. Start your review today and get a board-certified cardiac surgeon's perspective on your specific case.